Pliant Therapeutics price target lowered to $10 from $38 at Needham
Needham analyst Joseph Stringer lowered the firm’s price target on Pliant Therapeutics (PLRX) to $10 from $38 and keeps a Buy rating on the ...
Benzinga.com1 年
Joseph Stringer's Stock Ratings
Joseph Stringer is an analyst at Needham. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...
Vertex Pharmaceuticals’ JOURNA VX: Navigating Market Challenges Despite Promising ...
Needham analyst Joseph Stringer has maintained their neutral stance on VRTX stock, giving a Hold rating today.Invest with Confidence: Follow ...
The Argus12 天
Super Stringer: The Brighton mayor who made a mark on local communities
Born in 1894 to Joseph and Emma Stringer, Dorothy was an avid contributor to Brighton’s community from a young age. Although Stringer’s familial roots had historical weight in local services ...
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most ...
13. This analyst has an accuracy rate of 60%. Needham analyst Joseph Stringer reiterated a Hold rating on Sept. 13. This ...